UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 762

Sortiert nach

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

Annals of neurology, 2005-02, Vol.57 (2), p.176-179

2005

Link zum Volltext

Verfügbarkeit prüfen

1002 Incidence of peritoneal high-grade serous carcinoma after normal risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A388-A389

2024

Link zum Volltext

Verfügbarkeit prüfen

999 Significance of complete embedding of risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A439-A439

2024

Link zum Volltext

Verfügbarkeit prüfen

976 The impact of Covid-19 on the care of endometrial and ovarian cancer: a population-based study in the Netherlands

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A555-A555

2024

Link zum Volltext

Verfügbarkeit prüfen

EP173/#392 High-grade serous carcinoma in risk-reducing salpingo-oophorectomy specimens of asymptomatic carriers of a BRCA1/2 germline pathogenic variant

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A118-A118

2022

Link zum Volltext

Verfügbarkeit prüfen

EP185/#391 Role of extensive processing of risk-reducing salpingo-oophorectomy specimens in BRCA1/2 germline pathogenic variant carriers

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A123-A123

2022

Link zum Volltext

Verfügbarkeit prüfen

EP195/#447 Caregiver experience during the COVID-19 pandemic in the Netherlands

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A127-A127

2022

Link zum Volltext

Verfügbarkeit prüfen

EP196/#887 Impact of the COVID-19 pandemic on the care of patients with ovarian cancer

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A127-A128

2022

Link zum Volltext

Verfügbarkeit prüfen

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

BMC cancer, 2009-05, Vol.9 (1), p.163-163, Article 163

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands

Cancer epidemiology, 2023-08, Vol.85, p.102405-102405, Article 102405

2023

Link zum Volltext

Verfügbarkeit prüfen

HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in‐situ hybridisation

Histopathology, 2018-11, Vol.73 (5), p.852-863

2018

Link zum Volltext

Verfügbarkeit prüfen

EP269/#1005 BRCA1/2 testing rates in epithelial ovarian carcinoma: a focus on the untested patients

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A160-A160

2022

Link zum Volltext

Verfügbarkeit prüfen

2022-RA-440-ESGO BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A454-A454

2022

Link zum Volltext

Verfügbarkeit prüfen

Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens

European journal of cancer (1990), 2013-01, Vol.49 (1), p.132-141

2013

Link zum Volltext

Verfügbarkeit prüfen

Receptor conversion in distant breast cancer metastases

Breast cancer research : BCR, 2010-09, Vol.12 (5), p.R75-R75, Article R75

2010

Link zum Volltext

Verfügbarkeit prüfen

Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil’s dilemma for the surgeon: A systematic review and meta‐analysis

Acta obstetricia et gynecologica Scandinavica, 2021-08, Vol.100 (8), p.1369-1376

2021

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

International journal of gynecological cancer, 2023-08, Vol.33 (8), p.1260-1269

2023

Link zum Volltext

Verfügbarkeit prüfen

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis

Breast (Edinburgh), 2021-10, Vol.59, p.376-382

2021

Link zum Volltext

Verfügbarkeit prüfen

Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study

Acta obstetricia et gynecologica Scandinavica, 2023-03, Vol.102 (3), p.246-256

2023

Link zum Volltext

Verfügbarkeit prüfen

2022-RA-637-ESGO Five-year universal tumor screening of BRCA1/2 in epithelial ovarian carcinoma;is histotype-directed hr-deficiency testing justified?

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A248-A248

2022

Link zum Volltext

Verfügbarkeit prüfen

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter

Journal of Gynecologic Oncology, 2023, 34(6), , pp.1-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1936391-1936391

2021

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

International journal of cancer, 2012-09, Vol.131 (5), p.E670-E680

2012

Link zum Volltext

Verfügbarkeit prüfen

Variability in grading of ductal carcinoma in situ among an international group of pathologists

The journal of pathology. Clinical research, 2021-05, Vol.7 (3), p.233-242

2021

Link zum Volltext

Verfügbarkeit prüfen

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers

PloS one, 2013-02, Vol.8 (2), p.e56055

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 762

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(721)
Mit Volltextzugriff
(670)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

1002 Incidence of peritoneal high-grade serous carcinoma after normal risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers

999 Significance of complete embedding of risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

976 The impact of Covid-19 on the care of endometrial and ovarian cancer: a population-based study in the Netherlands

EP173/#392 High-grade serous carcinoma in risk-reducing salpingo-oophorectomy specimens of asymptomatic carriers of a BRCA1/2 germline pathogenic variant

EP185/#391 Role of extensive processing of risk-reducing salpingo-oophorectomy specimens in BRCA1/2 germline pathogenic variant carriers

EP195/#447 Caregiver experience during the COVID-19 pandemic in the Netherlands

EP196/#887 Impact of the COVID-19 pandemic on the care of patients with ovarian cancer

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands

HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in‐situ hybridisation

EP269/#1005 BRCA1/2 testing rates in epithelial ovarian carcinoma: a focus on the untested patients

2022-RA-440-ESGO BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens

Receptor conversion in distant breast cancer metastases

Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil’s dilemma for the surgeon: A systematic review and meta‐analysis

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis

Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study

2022-RA-637-ESGO Five-year universal tumor screening of BRCA1/2 in epithelial ovarian carcinoma;is histotype-directed hr-deficiency testing justified?

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

Variability in grading of ductal carcinoma in situ among an international group of pathologists

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers

Suchergebnisse filtern